CD21 Blocking Peptide

General Information

Product

CD21 Peptide

Description

Antigenic Blocking Peptide Complement Receptor Type 2 Antibody N-epitope

Verified Applications

Immmunodepletion, Competition Assay

Peptide Description

Synthetic peptide taken within amino acid region 650-700  on human Complement Receptor type 2 isoform X1 protein.

Accession #

NCBI:  XP_011507508.1

Physical Properties

Quantity

250 µg

Volume

100 µl

Form

Antigenic Blocking Peptide

Determinant

N-epitope

Storage

-20⁰C for long term storage

Application Protocol

Competition/Depletion assay

Refer to competition assay protocol

Protein

Uniprot #

P20023

Overview

Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation.

Molecular Function

Complement binding; DNA binding; Protein homodimerization activity

Subcellular Location

Membrane; Single-pass type I membrane protein

Expression

Mature B-lymphocytes, T-lymphocytes, pharyngeal epithelial cells, astrocytes and follicular dendritic cells of the spleen.

Structure

Interacts (via Sushi domain 1 and 2) with C3dg.

Alternative Nomenclature

C3DR antibody

CD21 antibody

CD21 antigen antibody

Complement C3d receptor antibody

Complement component (3d/Epstein Barr virus) receptor 2 antibody

Complement component receptor 2 antibody

Cr 2 antibody

CR antibody

CVID7 antibody

EBV receptor antibody

EBV-R antibody

Epstein Barr virus receptor antibody

EVBR antibody

SLEB9 antibody